《大行報告》高盛上調快手-W(01024.HK)目標價至91元 評級「買入」
高盛發表研究報告指,快手-W(01024.HK)去年第四季的收入和利潤勝該行及市場預期,同時今年以來廣告和直播的份額增長和盈利能力改善,以及樂觀的指引為當前的市場預期提供了上行空間,但快手仍是年初至今跑輸市場的三大中國互聯網公司之一。該行予集團目標價由89元上調至91元,維持「買入」評級。
該行認為,儘管宏觀復甦有所延遲,集團在邁向實現多個中期目標,即今年集團層面錄利潤、明年達4億日活躍用戶等方面,仍處於良好狀態。由於本年迄今股價累跌20%,該行認為,目前的估值仍可提供合理的風險回報,其電子商務將受惠於今年優於行業的復甦,以及持續的營運槓桿帶動的利潤率擴張。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.